SCHEMBL6437701

SCHEMBL6437701

[CH2]CCCOC(=O)CCCCC

nearest known ligand 0.70

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.70
PRSS1 P07477 1/20 0.58
PRSS2 P07478 1/20 0.58
PRSS3 P35030 1/20 0.58
DNM1 Q05193 1/20 0.58
TSHR P16473 1/20 0.55
NAAA Q02083 1/20 0.53
PAM P19021 2/20 0.53
HTR2C P28335 1/20 0.51
MAPT P10636 1/20 0.50
ALDH1A1 P00352 1/20 0.49
LMNA P02545 1/20 0.49
EPHX2 P34913 1/20 0.48
KDM4E B2RXH2 1/20 0.47
DUSP3 P51452 1/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7757774 0.98 DGKA (0.74) DGKAPRSS1PRSS2PRSS3DNM1
SCHEMBL7751793 0.98 DGKA (0.74) DGKAPRSS1PRSS2PRSS3DNM1
SCHEMBL4890999 0.98 DGKA (0.74) DGKAPRSS1PRSS2PRSS3DNM1
SCHEMBL7839859 0.98 DGKA (0.74) DGKAPRSS1PRSS2PRSS3DNM1
SCHEMBL7838151 0.98 DGKA (0.74) DGKAPRSS1PRSS2PRSS3DNM1
SCHEMBL7828305 0.98 DGKA (0.74) DGKAPRSS1PRSS2PRSS3DNM1
SCHEMBL3064415 0.94 DGKA (0.68) DGKAPRSS1PRSS2PRSS3DNM1
SCHEMBL7332890 0.94 DGKA (0.68) DGKAPRSS1PRSS2PRSS3DNM1
SCHEMBL7509234 0.94 DGKA (0.68) DGKAPRSS1PRSS2PRSS3DNM1
SCHEMBL667190 0.94 DGKA (0.61) DGKAPRSS1PRSS2PRSS3DNM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6897255-B1 Latex compositions containing ethylenically unsaturated esters of long-chain alkenols and applications thereof UNIVERSITY OF SOUTHERN MISSISSIPPI (US) 2005-05-24 US disclosed
US-6700006-B2 (METH)ACRYLATE ESTERS OF HYDROXY LONG-CHAIN OLEFINIC COMPOUNDS DERIVED FROM CASTOR OIL, FOR EXAMPLE; LATEX; WATERBORNE COATINGS, ADHESIVES, INKS; FORM WITHOUT USING VOLATILE ORGANIC COMPOUNDS (VOC'S) UNIVERSITY OF SOUTHERN MISSISSIPPI 2004-03-02 US disclosed
US-6653381-B2 Copolymers of acrylate or methacrylate esters of hydroxy long-chain olefinic compounds derived from nondrying oils, e.g. castor oil or lesquerella oil preferred; latex films; waterbased paints, coatings, contact and pressure adhesives UNIVERSITY OF SOUTHERN MISSISSIPPI 2003-11-25 US disclosed
US-6624223-B1 Crosslinkable copolymer comprising (meth)acrylated castor or lesquerella oil and ethylenically unsaturated monomers; cobalt, manganese, lead, zirconium, or calcium carboxylate drying agent; pressure sensitive adhesives, inks UNIVERSITY OF SOUTHERN MISSISSIPPI 2003-09-23 US disclosed
US-6599972-B2 Water soluble; low volatility solvents; odorless UNIVERSITY OF SOUTHERN MISSISSIPPI 2003-07-29 US disclosed
US-20020007080-A1 Novel internally plasticizing and crosslinkable monomers and applications thereof UNIVERSITY OF SOUTHERN MISSISSIPPI 2002-01-17 US disclosed
US-20010031883-A1 Novel internally plasticizing and crosslinkable monomers and applications thereof THE UNIVERSITY OF SOUTHERN MISSISSIPPI 2001-10-18 US disclosed
US-20010021739-A1 Latex compositions containing ethylenically unsaturated esters of fatty compounds and applications thereof THE UNIVERSITY OF SOUTHERN MISSISSIPPI (US) 2001-09-13 US disclosed
EP-0751133-B1 Pyrimidine compound, and liquid crystal composition and liquid crystal element using the same MITSUI CHEMICALS INC (JP) 2001-09-12 EP disclosed
EP-0796248-B1 CARBOSTYRIL DERIVATIVES AS ANTITHROMBOTIC AGENTS WESTERN THERAPEUTICS INST D (JP) 2001-08-16 EP disclosed
WO-1994008934-A1 ENANTIOMERIC RESOLUTION ALBEMARLE CORPORATION (US) 1994-04-28 WO disclosed
WO-1994008936-A1 ENANTIOMERIC RESOLUTION ALBEMARLE CORPORATION (US) 1994-04-28 WO disclosed
WO-1994008937-A1 ENANTIOMERIC RESOLUTION ALBEMARLE CORPORATION (US) 1994-04-28 WO disclosed
WO-1994008935-A1 ENANTIOMERIC RESOLUTION ALBEMARLE CORPORATION (US) 1994-04-28 WO disclosed
US-5278337-A Enantiomeric resolution of aryl-substituted aliphatic carboxylic acids ETHYL CORPORATION (US) 1994-01-11 US disclosed
US-5260482-A Enantiomeric resolution ETHYL CORPORATION (US) 1993-11-09 US disclosed
US-5256816-A Enantiomeric resolution ETHYL CORPORATION (US) 1993-10-26 US disclosed
US-5248813-A Enantiomeric resolution ETHYL CORPORATION (US) 1993-09-28 US disclosed
US-4808620-A ANTIINFLAMMATORY, ANALGESICS, ANTIPYRETIC, ANTIALLERGENS, ANTIARTHRITIC, ANTIRHEUMATIC AGENTS YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1989-02-28 US disclosed
EP-0254241-A1 Pyrazolopyridine compounds, their preparation and use Yoshitomi Pharmaceutical Industries, Ltd. (JP) 1988-01-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020007080-A1 Novel internally plasticizing and crosslinkable monomers and applications thereof LATS2, LATS1, LTA DGKA 543/4885PRSS1 4741/4885PRSS2 4615/4885
US-20010031883-A1 Novel internally plasticizing and crosslinkable monomers and applications thereof LATS2, LATS1, LTA DGKA 543/4885PRSS1 4741/4885PRSS2 4615/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.